Status:
RECRUITING
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
Lead Sponsor:
Hacettepe University
Conditions:
Systemic Sclerosis (SSc)
Scleroderma
Eligibility:
All Genders
7+ years
Brief Summary
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evalua...
Eligibility Criteria
Inclusion
- \*For a child diagnosed with scleroderma\*
- Cases diagnosed with scleroderma,
- Cases aged 7-18 years will be included.
Exclusion
- Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
- Cases that are not willing to participate in the study will be excluded.
- Having participated in a regular exercise program for the past 3 months
- Individuals who are not willing to participate in the study
- \*For adults diagnosed with scleroderma\*
- Inclusion Criteria:
- Individuals diagnosed with scleroderma,
- Individuals over the age of 18 will be included.
Key Trial Info
Start Date :
August 4 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 4 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07183072
Start Date
August 4 2025
End Date
August 4 2027
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Çankaya, Ankara, Turkey (Türkiye)